The Valley Desk

NCT03216499 · Interventional trial

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma

Overall registry status Completed

Phase 2

Conditions Recurrent Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov